Table III.
Relation of clinical and laboratory markers for venous thrombosis
| Variable | Univariable |
Multivariable |
||||
|---|---|---|---|---|---|---|
| OR | 95% CI | P value | OR | 95% CI | P value | |
| Age | 1.00 | 0.98-1.03 | .86 | – | – | – |
| Male sex | 2.64 | 1.19-5.84 | .02 | 2.37 | 1.01-5.56 | .048 |
| Hypertension | 0.81 | 0.39-1.65 | .56 | – | – | – |
| Hyperlipidemia | 0.65 | 0.31-1.36 | .25 | – | – | – |
| Diabetes | 0.94 | 0.46-1.94 | .87 | – | – | – |
| Tobacco (active user) | 0.34 | 0.04-2.92 | .33 | – | – | – |
| Coronary artery disease | 1.60 | 0.63-4.09 | .33 | – | – | – |
| Previous DVT or PE | 1.24 | 0.34-4.49 | .74 | – | – | – |
| Respiratory disease | 1.17 | 0.46-3.01 | .74 | – | – | – |
| Active malignancy | 2.25 | 0.54-9.45 | .27 | – | – | – |
| DIC | 3.89 | 0.89-17.08 | .07 | – | – | – |
| Admission laboratory markers | ||||||
| D-dimer, per 100-U increase | 1.006 | 0.992-1.019 | .41 | – | – | – |
| Fibrinogen, per 100-U increase | 1.046 | 0.792-1.382 | .75 | – | – | – |
| PT | 1.084 | 0.970-1.211 | .16 | – | – | – |
| PTT | 1.009 | 0.987-1.032 | .40 | – | – | – |
| Platelet count, per 1000-U increase | 1.482 | 1.035-2.122 | .03 | 1.252 | 0.832-1.882 | .28 |
| CRP, per 10-U increase | 1.049 | 1.009-1.089 | .02 | 1.040 | 0.998-1.082 | .06 |
| hs-Troponin T | 1.000 | 0.998-1.002 | .92 | – | – | – |
CI, Confidence interval; CRP, C-reactive protein; DIC, disseminated intravascular coagulation; DVT, deep vein thrombosis; hs, high sensitivity; OR, odds ratio; PE, pulmonary embolism; PT, prothrombin time; PTT, partial thromboplastin time.
Boldface P values represent statistical significance.